73
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Oxidative stress-mediated cardiac mast cell degranulation

, , , &
Pages 1293-1301 | Received 03 Jul 2009, Accepted 05 Aug 2009, Published online: 27 Jul 2010
 

Abstract

Pulmonary mast cell degranulation is a well-characterized response to diesel exhaust exposure. A primary constituent of fossil fuel combustion is sulfur dioxide (SO2). SO2 was shown to induce mast cell degranulation in an immortalized cell line secondary to induction of intracellular oxidative stress; however, it is not known whether SO2-induced oxidative stress directly triggers the activation of cardiac mast cells. Accordingly, this study sought to determine whether Na2SO3 induces degranulation of cardiac mast cells, and furthermore whether cardiac mast cell activation may be prevented by inhibition of oxidative stress. To this end, cardiac mast cells were isolated from epicardial surface of the heart and incubated with increasing concentrations of Na2SO3 (0, 0.5, or 5 mM). Antioxidant compounds targeting different mechanisms of free radical generation, including ebselen, diphenyleneiodonium (DPI), or α-tocopherol, were incubated with 5 mM of Na2SO3 in order to determine their efficacy in preventing mast cell degranulation. Na2SO3 induced a significant concentration-dependent histamine release from cardiac mast cells ranging from 8.87% to 18.86%, which was prevented by ebselen. No effect was observed with DPI and α-tocopherol under these conditions. In conclusion, these findings indicate that SO2 is capable of producing cardiac mast cell degranulation in vitro; however, the variable effectiveness of the three antioxidants evaluated is indicative of a multifactorial mechanism mediating SO2-induced cardiac mast cell degranulation. The particular effectiveness of ebselen in preventing mast cell degranulation may be related to its multiple mechanisms of preventing oxidative stress.

Acknowledgments

This study was supported in part by funding from the Environmental Protection Agency (EPA) RD831953 (GLB) and by Philip Morris USA Inc. and Philip Morris International and American Heart Association Postdoctoral Fellowship (0825510E) (SPL). Although the research described in the article has been funded in part by the US EPA's Science to Achieve Results (STAR) program through grant RD831953, it has not been subjected to any EPA review and therefore does not necessarily reflect the views of the agency, and no official endorsement should be inferred.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 61.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 2,970.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.